Starting Together: Tell Us the Big Picture

• In one paragraph, describe this project and the fixed occupancy date that cannot slip.
• What type of facility is this? Options: Healthcare – Inpatient (hospital/tower), Healthcare – Outpatient/Clinic, Research / Lab, Higher education – Academic, Manufacturing / Production, Data center, Corporate office, Other
• Which of these budget bands best matches your current cost target (including contingency)? Options: Under $10M, $10M–$50M, $50M–$150M, $150M–$500M, Over $500M, Undecided / Confidential
• Which delivery or procurement approach are you currently favoring? Options: Construction Manager at Risk (CMAR), General Contractor / Design-Bid-Build, Design-Build, Integrated Project Delivery (IPD), Owner-managed procurement, Undecided
• Who sponsored the project internally (Board, CFO, CEO, Department head, other)? Please name role and, if possible, person.
• Who on your team will be the day-to-day contact for preconstruction and decisions (name, role, preferred contact)?

Who Actually Signs Off When It Matters?

• If one stakeholder could unilaterally delay the occupancy or force a major scope cut, who would it be—and what power do they hold that would allow it?
• For the people listed below, indicate their decision authority and typical reaction to cost vs. schedule tradeoffs. Options: Board (Strategic/Yes/No), CFO (Financial approval), VP Capital Planning (Program level), Director of Facilities (Operational acceptance), Clinical leadership (Functional acceptance), Procurement (Contracting & compliance), External funder / lender, Other
• Which milestones require board or executive-level sign-off (schematic approval, GMP, financing, occupancy)? Select all that apply and note expected approval windows. Options: Schematic/design approval, Budget/GMP acceptance, Bonding/insurance confirmation, Permit issuance, Occupancy acceptance, Other
• What is each stakeholder’s single ‘must not slip’ item (e.g., revenue date, clinical accreditation, production ramp)? Please list stakeholder and their non‑negotiable.
• How quickly can final decisions be pulled together if a trade‑off is required (days, weeks)? Options: Within days (1–5), Weeks (2–6), Months, Unclear / depends on the issue

The Risk Stories You’ve Lived — And Those You Fear

• What’s one past project close to this size/type that taught your team a harsh lesson—what went wrong and who still remembers it?
• Which of these recurring risk patterns have you experienced or worry will recur on this job? Options: Subcontractor sequencing failures, Late design changes, Permit/authority delays, Procurement lead‑time surprises, Owner-side decision delays, Scope gaps discovered at pricing, Staffing turnover, Other
• How often do project controls (cost/schedule reports) reflect reality on your projects—usually accurate, often optimistic, frequently outdated, or unreliable? Options: Usually accurate, Often optimistic, Frequently outdated, Unreliable / not trusted
• When a risk materialized previously, how did it feel internally—embarrassment, finger-pointing, calm correction, or financial panic? Tell the story and the human impact.
• Which external constraints (procurement rules, union agreements, bonding limits, grant conditions) could realistically prevent a proposed mitigation from being implemented? Options: Public procurement rules, Union labor requirements, Bonding capacity limits, Grant / funder restrictions, Vendor exclusivity agreements, None of the above / flexible
• How much institutional memory do you have for projects like this—do you have post‑mortems, centralized lessons learned, or mostly tribal knowledge? Options: Well-documented lessons learned, Some documentation, partial memory, Mostly tribal knowledge, None

If Schedule Could Speak, What Would It Demand?

• If the occupancy date slid by one quarter, what concrete business outcomes would be affected (lost revenue, enrollment, production ramp, regulatory deadlines)? Please quantify if possible.
• What tolerance do you have for schedule variance before you trigger executive escalation or contract remedies? Options: Zero tolerance – immediate escalation, Up to 2 weeks before escalation, Up to 1 month, 1–3 months, Depends on the reason
• Which parts of the schedule do you consider absolutely immovable (critical handoffs, phasing for occupied operations, equipment install windows)?
• How do you currently quantify schedule risk and early warning—do you use rolling lookaheads, risk registers with scenario dates, float ownership, or something else? Options: Rolling lookahead schedules, Risk register with scenarios, Float ownership tracking, Ad hoc / no formal method, Other
• If we proposed accelerated structural sequencing that shortens critical path by X weeks but increases near-term cash flow, how would your team evaluate that tradeoff? Options: Favor schedule acceleration, Prefer cash flow protection, Need board/CFO approval, Depends on magnitude

Where Baselines Break: Controls, Data, and Assumptions

• What makes your current cost and schedule baseline believable—or not—on day one?
• Which project control tools or systems do you use today for cost/schedule/risk reporting? Options: Primavera P6, MS Project / Project Online, Proprietary in-house spreadsheet, CostX / Hard dollar tools, Owner's ERP / financial system, None / informal
• How frequently are cost and schedule forecasts refreshed, and who reviews them? Options: Weekly, Biweekly, Monthly, Ad hoc, Never
• Describe one assumption in your baseline that keeps you awake at night—why is it fragile?
• Have you performed independent estimate cross-checks or third‑party schedule reviews during design? If so, what changed as a result? Options: Yes — multiple reviews and adjustments made, Yes — review but no major changes, No — not yet, Planned but not scheduled
• Who owns change management and baseline acceptance once construction begins? Options: Owner PM, Program Controls team, Finance/CFO, Steering committee/board, Not defined

How Much Skin Is on the Line? Money, Incentives, and Trust

• If commercial terms shifted to place more at‑risk on the contractor to protect your occupancy and budget, how comfortable would you be with that approach? Options: Very comfortable, Somewhat comfortable, Hesitant — need specifics, Not comfortable
• Which fee and incentive structures have you used or considered (fixed fee, guaranteed maximum price, bonuses for early completion, pain/gain share)? Options: Fixed fee, GMP, Time & materials, Early completion bonus, Pain/gain share, Other
• What bonding and insurance requirements are mandatory for contracts on this program? Options: Performance & payment bonds required, Partial bonding, Specific insurance coverages required (list), No formal bonding requirement, Unknown
• Have prior contracts created perverse incentives (e.g., low fee to win, then maintain scope creep) that you want to avoid? Tell the specific example.
• What governance cadence feels right to you (weekly site meetings, monthly executive reviews, quarterly board updates)? Options: Weekly site-level, Biweekly leadership, Monthly executive, Quarterly board, Combination (specify), Undecided
• What would you see as a fair baseline acceptance threshold for cost and schedule before construction starts (e.g., +/- 3% cost, +/- 30 days)?

A Day in Construction: Phasing, Occupied Ops, and What Never Stops

• Tell us about the occupied operations we must protect—what activities, departments, or processes cannot be disrupted under any circumstances?
• Which logistics constraints are non‑negotiable (site access windows, noise curfews, deliveries through specific gates, contractor parking)? Options: Fixed access windows, Noise restrictions, Limited delivery gates, No on-site laydown, Security vetting for crews, Other
• How transferable is your facilities staff—can you dedicate existing staff to construction oversight, or will you rely on external O&M consultants? Options: Dedicated internal staff available, Partial support with external supplement, Rely entirely on external consultants, Undecided
• Which trades or scopes do you most want the contractor to self‑perform (concrete, structural steel, finish carpentry, MEP, other)? Options: Concrete, Structural steel, Finish carpentry, MEP, Envelope/Cladding, Other
• When it comes to phasing around occupied spaces, what’s the single biggest worry you have that you’d like us to eliminate?
• Are there hard permit or inspection windows (e.g., life‑safety system tie‑ins) that determine certain work sequences? Options: Yes — provide dates/details, Maybe — need to confirm, No

What Would Success Look and Feel Like?

• Beyond hitting the occupancy date, what measurable outcomes would make this project a success for you (on-time occupancy, budget tolerance, commissioning acceptance, user satisfaction)? Options: On-time occupancy, Within agreed cost tolerance, Minimal value engineering, Commissioning completed on schedule, High user acceptance, Other
• What cost tolerance is acceptable before you consider stopping scope versus funding an overrun (percent or dollar value)?
• How do you define acceptable value engineering—what elements can be adjusted and what must be preserved at all costs?
• What owner acceptance criteria will be used at key milestones (substantial completion, commissioning, final closeout)? Please list top 3 criteria.
• How would you like lessons learned and ongoing issue tracking handled post‑occupancy (regular reports, shared channel, scheduled retrospectives)? Options: Weekly reports + dashboard, Shared collaboration channel (e.g., Slack/MS Teams), Formal lessons-learned sessions, Ad hoc
• If we delivered the project on time and within tolerance, what would that enable for your organization (revenue, enrollment, production, strategic confidence)?

Red Flags & Deal Killers — Tell Us What Would Make You Walk Away

• What are the absolute non‑starters in a partner relationship for this project (pricing structure, lack of bonding, no self‑perform capability, poor safety record)? Options: Unacceptable pricing model, Insufficient bonding, Lack of self-perform for critical trades, Poor safety/EMR/TRIR, No embedded preconstruction capability, Other
• Has your team previously terminated a contractor or vendor on a similar program? If yes, what specifically triggered that decision? Options: Yes — schedule failure, Yes — cost overruns, Yes — safety issues, Yes — quality/defects, No
• Which documents or assurances would give you confidence to proceed to a commercial commit (detailed baseline, bonded GMP, insurance evidence, staffing plan)? Options: Baseline schedule & budget, Bonded GMP, Insurance certificates, Key personnel resumes & commitments, Procurement lead-time plan
• What unresolved political or organizational issues (internal turf, unions, board concerns) could derail this deal if not surfaced and addressed early?
• If we identify a critical issue in discovery that would increase cost or delay occupancy, how would you prefer we present it—high-level with options, full forensic detail, or staged recommendations? Options: High-level with options, Full forensic analysis, Staged recommendations with quick fixes first, Other

Project Snapshot — let’s get oriented

• Which best describes this capital program? Options: New patient tower / healthcare, Research or lab building / higher education, Manufacturing line or plant, Data center / mission critical, Office or mixed-use, Other
• What is the fixed, non‑negotiable occupancy or go‑live date (month/year)?
• What is the board‑approved budget band for construction (hard cost)? Options: <$10M, $10M–$50M, $50M–$150M, $150M–$500M, >$500M, Not yet finalized
• Who is the single point owner for capital decisions on your side (title/role)? Options: VP Capital Planning, Director of Facilities, CFO, CEO/President, Program Manager / PMO, Other
• Right now, how confident are you that the program will meet both the occupancy date and the approved budget? Options: Very confident, Somewhat confident, Uncertain / mixed signals, Not confident

If This Slips, What Breaks?

• If the occupancy date moves by 30–90 days, what immediate financial or operational consequences would you face?
• Which of these consequences worry you most and why? Options: Revenue recognition delay, Patient capacity shortfall, Lost enrollment/research grants, Production downtime, Regulatory/contractual penalties, Other
• Have you quantified the dollar or KPI impact tied to a missed date (e.g., monthly revenue loss, delayed grant start)? If so, please give the figure or KPI.
• Which stakeholders will face the most political pressure if the date slips (select all that apply)? Options: Board / Trustees, CFO / Finance, Clinical leadership / Department heads, Research leadership, Operations / Production, External funders
• What contingency plans—if any—have you shared with the board or executive team to address a schedule slip? Options: Detailed contingency plan exists, High‑level contingency discussed, No contingency shared yet, Contingency depends on contractor proposals

Where Things Tend to Falter — Tell Me the True History

• Think about your last major project that struggled—what single event from that program could repeat here if not addressed?
• Which of these past risk events occurred on prior programs (select all that apply)? Options: Major schedule slip >90 days, Deep value engineering that changed program, Subcontractor default or mobilization failure, Long‑lead material delays, Permitting or inspections hold, Contractual claims or litigation
• How were those events resolved and how long did recovery take (weeks/months)?
• Where did you see the weakest project controls in past programs (select up to three)? Options: Baseline schedule fidelity, Change order governance, Estimate granularity and tracking, Procurement sequencing, Risk register ownership, Commissioning coordination
• During those events, who was responsible for day‑to‑day risk tracking and escalation? Options: Internal PM/PMO, Owner's rep/consultant, External CM/GC, Design team, Shared responsibility, unclear ownership
• How much staff turnover occurred during the recovery period, and how did that affect continuity? Options: No turnover, Minor turnover (<10%), Moderate (10–30%), High (>30%)

What’s Really Locked In — Constraints We Must Respect

• Tell us about any immovable constraints beyond the occupancy date (provocative): what are the true 'red lines' we must never cross?
• Which of these constraints are contractually or politically non‑negotiable? Options: Occupancy date, Maximum soft cost limit, Minimum clinical program size, Operational uptime for occupied areas, Bonding/insurer requirements, Other
• Are there board‑approved milestones or funding release dates linked to project performance? Options: Yes — clearly defined, Yes — loosely defined, No, Under discussion
• What internal approval windows or financial close dates create hard procurement deadlines?
• Which internal stakeholders must sign off on major scope or baseline changes (list titles/roles)?

What Are You Willing to Change to Protect the Date?

• If protecting the occupancy date required accepting increased early cost certainty or an at‑risk delivery model, how willing would you be to shift procurement and contracting approach? Options: Very willing, Somewhat willing, Open but needs board approval, Unwilling
• Which contract delivery models are you open to exploring to transfer schedule risk? Options: CM at‑risk (CMAR), Design‑build, Traditional GC, Cost‑plus with GMP, Hybrid / phased authority
• Would you consider embedding preconstruction services (estimating + scheduling in‑house during design) for fee to lock baseline earlier? Options: Yes — preferred, Maybe — need cost justification, No — prefer post‑design procurement
• How tolerant are you of at‑risk commitments (liquidated damages, guaranteed dates, shared savings)? Options: High tolerance, Moderate tolerance, Low tolerance, Unknown / need counsel input
• What internal approvals or policy changes would be required to adopt a more at‑risk model?

Who Really Holds the Keys—Decision Dynamics and Politics

• Who on your team can veto a proposed change that materially protects schedule or budget—and what motivates their veto power?
• Map the decision roles for this program — who signs the cost baseline, who approves change orders, and who accepts final occupancy? Options: Board / Trustees, CFO, VP Capital Planning, Director of Facilities, Clinical/Academic Leadership, External funder/partner
• How fast can those decision‑makers convene for an urgent approval (hours, days, weeks)? Options: Within 24 hours, 1–3 days, One week, Multiple weeks
• What forms of communication move them: quick executive summary, data dashboard, in‑person briefing, formal packet? Options: Executive summary (1–2 pages), Dashboard with KPIs, In‑person briefing, Formal board packet, Email thread
• Who else outside the owner organization (regulator, funder, tenant) must be consulted before major decisions?

Hidden Constraints — Procurement, Subcontractors, and Long Lead Items

• What single procurement or subcontractor dependency is most likely to derail your critical path if it isn't secured early?
• Which trades or scopes do you expect to self‑perform versus subcontract (select all that apply)? Options: Concrete / foundations, Structural steel erection, Finish carpentry, MEP trades, Commissioning, Specialty vendors (lab, medical gas)
• Which long‑lead materials or equipment are already on your radar as potential bottlenecks? Options: Medical equipment, Boilers / chillers, Steel framing, Precast / curtain wall, Critical machinery, HVAC long‑lead
• Have you prequalified or held procurement windows with key suppliers/subcontractors? Options: Yes — prequalified and locked, Yes — prequalified but not locked, No — not started, Not applicable
• Describe your current project controls stack (software, reporting cadence, cost/schedule model fidelity).
• Are there bonding capacity, insurance constraints, or funding covenants that limit how risk can be assigned? Options: Yes — material limits, Some limits but manageable, No significant constraints, Not sure / need to check

What Would Success Actually Look and Feel Like?

• Beyond 'on time', name the three measurable signals that would make you say, 'They nailed it.'
• Which KPIs matter most to you during delivery (select top three)? Options: Final cost variance vs. baseline, Schedule variance to critical milestones, Punchlist completion days, Commissioning success rate, Occupancy handover quality, Safety metrics (EMR, TRIR)
• What is an acceptable final cost tolerance and the maximum allowable value engineering (VE) you will accept without changing core program? Options: <2% cost tolerance / no VE, 2–5% / limited VE, 5–10% / acceptable VE, >10% / significant VE allowed, Undetermined
• How should owner acceptance be verified—what documents or tests are required for 'acceptance'? Options: Commissioning reports, Owner operational testing, Punchlist sign‑off, Third‑party inspection, Formal certificate of occupancy
• Who signs final acceptance and what evidence will satisfy them?

Small Tests, Big Confidence — early proof we can protect your baseline

• What early proof point during preconstruction would make you confident we can hold the baseline (provocative): a guaranteed milestone, a locked long‑lead buy, or a validated critical path?
• Which rapid deliverable would you value most in the first 60–90 days? Options: Validated cost model to +/-X%, Critical path schedule with float analysis, Procurement windows and supplier commitments, Risk register with mitigation plan, Site logistics and phasing plan
• How much access do we need to your internal data, design models, and decision‑makers to run these tests effectively? Options: Full access, Limited access with controls, Access via appointed delegates, Minimal access — high level only
• What format and frequency of early reporting would convince your executive team (scorecard, deep dive, workshop)? Options: Weekly scorecard, Biweekly deep dive, Monthly executive package, Ad hoc workshops
• Who must sign off on these early POC deliverables for you to proceed to contract?

What Keeps You Up That We Must Own

• Which single responsibility related to schedule, quality, or safety do you explicitly want the contractor to guarantee?
• Would you expect the contractor to self‑perform concrete/steel and lock crews for critical path work? Options: Yes — required, Preferred but negotiable, No — willing to rely on subs
• Which of these commercial protections are non‑negotiable for you? Options: Performance bonds, Professional liability, Liquidated damages, At‑risk GMP, Insurance limits beyond standard
• What governance cadence (executive, steering, operational) gives you comfort, and who should attend each? Options: Ad hoc escalation only, Weekly operational, Biweekly program, Monthly executive/board
• What staffing continuity expectations do you have for project leadership (e.g., single PM through closeout)? Options: Single PM throughout, Core team continuity with backups, Accept some turnover with knowledge transfer, Undecided

Next Steps — decision map and commitments to move forward

• If we left this meeting with one commitment from you that would materially change risk exposure, what must that commitment be?
• Would you be willing to authorize embedded preconstruction services (estimating + schedule) on a defined fee to begin locking the baseline? Options: Yes — ready to authorize, Maybe — need internal approvals, No — prefer different approach
• Who needs to attend a formal kickoff to authorize preconstruction and by when can they meet? Options: VP Capital Planning, CFO, Director Facilities, Program Manager/PMO, Clinical leadership, Board representative
• What documentation, approvals, or deliverables do you need from us to start procurement windows?
• How would you like progress reported back and at what cadence to satisfy your leadership (format and frequency)? Options: Weekly dashboard + monthly executive, Biweekly scorecard, Ad hoc major milestone briefings, Real‑time dashboard access only

Project Snapshot: Quick Orientation

• What is the project name, your organization, the fixed occupancy date, and the phase we are in today?
• Which building type best describes this work? Options: Acute care hospital / patient tower, Outpatient clinic / ambulatory, Research / lab facility, Higher education building, Manufacturing plant / production facility, Data center, Other
• Which delivery method and commercial structure is currently planned or in place? Options: Construction manager at risk (CMAR), General contractor (GC) lump-sum, Design‑bid‑build, Owner managed with trades, Progressive design‑build, Undecided / evaluating options
• What size band describes the total project construction value? Options: Under $10M, $10M–$50M, $50M–$150M, $150M–$500M, Over $500M
• Who on your side is the single point of accountability for program decisions and baseline acceptance?

If Key People Walked Tomorrow, Would We Notice?

• Imagine your project director or facility lead left six weeks before mobilization—what immediate gaps would that create?
• Which roles are mission‑critical for a seamless deployment and who are the current named individuals? Options: Project executive / sponsor, Project manager, Design liaison / A/E contact, Procurement lead, Site logistics manager, Field superintendent, MEP superintendent, Commissioning lead, Other
• Do you have confirmed backups or transition plans for each critical role listed? Options: Documented backups and shadowing in place, Backups identified but not fully transitioned, Backups not identified, Prefer external partner to provide continuity
• How stable has your staffing been on recent large projects—any pattern of last‑minute departures or turnover we should know about? Options: Very stable (rare turnover), Occasional role changes, Frequent turnover in last 12 months, High churn historically
• If continuity risk materializes, how quickly can your organization appoint a replacement or approve an external partner to fill the role? Options: Within 1 week, 1–3 weeks, 3–6 weeks, Longer than 6 weeks, Unsure
• How would losing a key internal person make you feel about meeting the occupancy date—confident, worried, or urgent? Explain briefly.

Which Procurement Lead Times Are We Underestimating?

• If a single long‑lead item slips six weeks, which procurement item would cause the largest schedule cascade? Options: Structural steel, Precast / concrete elements, Chillers / major HVAC equipment, Elevators/escalators, Specialty lab or medical equipment, Critical MEP prefabrication, Other
• Please list the top 6 long‑lead items you currently expect on this project (include vendor names if known).
• For each long‑lead item you named, what is the procurement route and current estimated lead time? Options: Owner‑provided long lead, Owner‑procured through vendor, Contractor procurement (GC/CM), Design‑assist/vendor partnership, Undecided
• Have you experienced procurement hold‑ups on past projects from the same suppliers or market? If yes, describe one example and its impact.
• What level of contingency do you currently plan to hold on long‑lead items (schedule buffer and cost contingency)? Options: No contingency, Minimal (1–2 weeks / 0–2%), Moderate (3–6 weeks / 3–5%), Significant (>6 weeks / >5%), Unsure
• Would you consider vendor lock‑ins and early buyouts to protect the critical path? If yes, which packages are highest priority?

Are Permits a Paper Chase—or a Schedule Hammer?

• If permitting took twice as long as expected, what part of the schedule or budget would it most threaten? Options: Mobilization date, Foundation / structural start, MEP rough‑in, Commissioning and occupancy, Finance / funding draw schedule, Other
• Which permits and regulatory approvals are critical before any site work can begin? Options: Building permit, Demolition permit, Environmental / remediation, Fire marshal approval, Healthcare licensing / facility certification, Utility service permits, Other
• What is the current status and estimated review time for each major permit you listed?
• Have you had prior projects delayed by municipal or agency reviews? Tell us one story—how long was the delay and what caused it?
• Who is the agency contact or permit expeditor you currently work with, and what leverage do they have to accelerate approvals?
• Would you be open to targeted pre‑submittal reviews or agency engagement sessions to reduce unknowns? (This is different from full permitting.) Options: Yes — we want that, Maybe — need more info, No — prefer to manage internally

How Will the Site's Daily Life Actually Work?

• If construction begins while operations stay live, what single site constraint would be most disruptive to ongoing operations? Options: Restricted access routes, Noise and vibration, Infection control / dust, Utility shutdowns, Parking and deliveries, Security / patient privacy, Other
• Which zones will remain occupied and what are their peak activity periods we must protect?
• Do you have an initial phasing strategy for occupied operations (describe phases and approximate durations)?
• What site access controls, credentialing, and infection control protocols do contractors need to follow on day one? Options: Badge access and escorts, Full TB/health screening, Dedicated entry separate from staff, Restricted PPE and air handling controls, Other
• How do you prefer deliveries and material staging to be managed on constrained days—scheduled windows, off‑site staging, or night/weekend deliveries? Options: Scheduled windows, Off‑site staging with just‑in‑time delivery, Night/weekend deliveries, Combination (specify), Undecided
• Share one recent example where a site logistics decision either protected or disrupted operations—what happened and what did you learn?

What's Already Non‑Negotiable?

• If we had to protect three immutable project constraints right now, which would they be (rank or list)? Options: Fixed occupancy date, Maximum allowable cost overrun, Specific clinical / production spaces need on day 1, Critical safety or compliance milestone, Bonding/insurance thresholds, Other
• What cost tolerance exists before the owner directs value engineering, and what parts of scope are off limits for VE? Options: <2% cost increase, 2–5%, 5–10%, >10%, No defined tolerance / TBD
• Are there any contract provisions, board conditions, or external funding deadlines that make certain dates or costs legally non‑negotiable? Options: Yes — legally binding, Yes — strongly preferred, No formal constraints, Unsure
• Who from the owner's side must sign off on baseline acceptance for schedule and budget, and what is their decision timeline?
• If a late‑breaking scope change is requested, what governance process would you expect to evaluate its impact? Options: Change control board with cost/schedule analysis, Executive sponsor approval only, Tightly restricted — not allowed, Ad hoc review

What Keeps You Up at Night — Real Risks & Past Repeats

• Which single past project failure or near‑miss would you most want to avoid repeating here?
• Have you experienced repeated vendor or subcontractor failures on similar projects? If yes, which trades or packages are highest risk? Options: Structural trades (concrete/steel), MEP trades, Special systems / medical gas, Exterior envelope, Finishes, Other
• How do you currently track and escalate emerging risks—who gets alerted and at what thresholds? Options: Weekly risk register with assigned owners, Monthly executive updates, Only when issues arise (ad hoc), Formal dashboard with triggers
• Which project controls tools or reports do you rely on today, and where do they fall short? Options: Earned value / cost forecasting, Schedule CPM and float analysis, Procurement tracker, Site logistics dashboard, Risk register with mitigation plans, Other
• What would a successful mitigation look like for your top risk—timing, ownership, and acceptable cost to resolve?

Ready to Mobilize? Decision Gates & Quick Wins

• What single go/no‑go trigger would make you pause mobilization even if everything else seems ready? Options: Unresolved permit(s), Critical staff not confirmed, Major long‑lead item not procured, Site access / logistics unresolved, Commissioning plan incomplete, Other
• Which three items on a pre‑deployment checklist give you the most reassurance (e.g., bonded crews locked, permits in hand, deliveries staged)?
• What contingency triggers (time or cost) should automatically shift us into an accelerated mitigation mode? Options: Schedule slip >2 weeks, Cost overrun >3%, Vendor non‑performance, Permit denial / stop‑work, Other
• Who must attend the pre‑mobilization governance call and who has authority to greenlight mobilization?
• If we prioritize three quick wins in the next 30 days to harden readiness, which would you choose from this list? Options: Confirm critical staffing continuity, Lock early procurement for top long‑lead items, Secure key permits or agency agreements, Finalize site access & delivery plan, Establish a shadow schedule with float analysis, Other
• Realistically, how soon can we run a joint pre‑deployment readiness review (date or timeframe)? Options: Within 1 week, 1–2 weeks, 2–4 weeks, 1–2 months, Unsure

Quick Snapshot — Where We Start Together

• Which of these best describes the project we’re talking about? Options: New patient tower / hospital expansion, Research or lab building, University academic building, Manufacturing/production facility, Data center / critical infrastructure, Other
• What is the board‑approved occupancy date (MM/YYYY) or the fixed milestone we cannot miss?
• What is the current baseline construction budget (or budget range) we should use for early alignment? Options: Under $10M, $10M–$50M, $50M–$150M, $150M–$500M, Over $500M, Budget not finalized / TBD
• Who holds final sign‑off for budget and occupancy decisions? Name role(s) and whether they are internal (Owner) or external (Board/Trustees).
• Why is this date non‑negotiable? (e.g., revenue recognition, enrollment start, production ramp, lease start) Options: Revenue recognition / financial close, Academic term or enrollment, Production/operations ramp, Lease or tenant obligation, Regulatory requirement, Other

If This Project Slid One Day, Who Would Notice First?

• If the schedule slipped by 60 days, which stakeholder would feel the impact first and how?
• Which internal groups have veto power or hard constraints (Facilities, Clinical Ops, IT, Regulatory, Finance, Academic Affairs)? Options: Facilities, Clinical Operations, IT/Infrastructure, Regulatory/Compliance, Finance/CFO, Academic Affairs/Provost, Other
• Has your governance body set milestone 'must not slip' dates for multiple stakeholders? If so, where are the most fragile handoffs?
• How emotionally or politically sensitive is missing this occupancy date inside your organization? (share concrete consequences or prior examples) Options: Severe — board/funding at risk, High — major program impacts, Moderate — operational adjustments, Low — contingency available
• Who in your team we should consider a champion for change versus a pragmatic skeptic we need to win over?

Where Budget and Reality Keep Missing Each Other

• When you look back at recent projects, what are the top causes of cost growth you’ve actually experienced (procurement, scope gaps, latent conditions, VE, owner change)? Options: Procurement delays / market escalation, Incomplete scope at design handoff, Owner‑driven scope changes, Unforeseen site conditions, Subcontractor performance, Regulatory rework, Other
• How accurate have your preconstruction estimates been on comparable projects (variance to final GMP or final cost)? Options: Within 2–5%, Within 5–10%, 10–20%, Over 20%, No comparable data
• Tell us about a recent risk event that repeated across projects—what happened and how long did the recovery take?
• What procurement constraints or internal policies (e.g., mandatory competitive bid, preferred subcontractor lists, union rules, bonding thresholds) will shape how we source trade work?
• How comfortable are you with an at‑risk delivery model where the contractor self‑performs critical structural scope and carries schedule/cost responsibility? Options: Very comfortable — prefer at‑risk, Somewhat comfortable — need more detail, Neutral, Prefer fee‑based CM, Not comfortable

What’s Getting in the Way of Predictable Schedules?

• We often see critical‑path control through who controls concrete/steel—who currently owns the structural scope and schedule levers on your program? Options: GC will self‑perform, Designated subcontractor, Multiple trade contractors, Owner self‑perform, Not yet determined
• Have phased occupancy or occupied‑campus logistics been required? If yes, where have the toughest interfaces been? Options: Occupied hospital wings, Active labs, Live production floors, Student housing/occupied campus, None required
• How do you currently verify milestone acceptance and owner acceptance criteria—are punch lists, commissioning, and OT/IT handoffs centralized or fragmented? Options: Centralized process with single owner, Multiple teams with coordinated checkpoints, Ad hoc and situational, No defined process yet
• Which permit or long‑lead items have the highest risk of delaying mobilization (e.g., MEP interfaces, specialty equipment, approvals)?
• When schedule pressure mounts, where does the organization tend to make compromises—and with what consequences?

What Would On‑Time, On‑Budget Really Mean to You?

• If the project hit the occupancy date and budget baseline exactly, what practical outcomes would that enable for your organization?
• What are your measurable success signals for acceptance (e.g., commissioning test pass rates, percent of punch completed, patient flow readiness)? Options: 100% commissioning pass, 90–99% critical test pass, Punch list < X items, Clinical simulation completed, Other — specify
• What is your acceptable cost tolerance before you require formal change control or board notification (percentage or dollar threshold)? Options: <1%, 1–3%, 3–5%, 5–10%, >10%
• How far can value engineering erode program function before it becomes unacceptable? Describe must‑keep elements versus negotiable items.
• Who will sign final owner acceptance—name role(s) and any departmental checklists they require?

If We Designed the Delivery Around Your Constraints, What Would Change?

• Which of these delivery features would be highest value to your team: embedded preconstruction estimating, self‑perform structural crews, guaranteed schedule milestones, or integrated commissioning? Options: Embedded preconstruction estimating, Self‑perform structural scope, Guaranteed schedule milestones / at‑risk delivery, Integrated commissioning and OT readiness, Phased occupancy planning
• How important is continuity of personnel (estimating, PM, superintendent) to you, and how long would you expect core team members to stay engaged? Options: Critical — same team through completion, Important — low turnover, Some turnover acceptable, Not a major concern
• If we proposed locking self‑perform crews on the critical path, what concerns would you want us to address first (cost certainty, bonding, safety, schedule control)? Options: Cost certainty, Bonding/insurance, Safety/EMR record, Impact on subcontractor market, Quality control
• What reporting cadence and level of detail does your governance team require during preconstruction and into construction (weekly schedule, earned value, risk register)? Options: Weekly schedule + monthly earned value, Biweekly status and risk updates, Monthly executive summary, Real‑time dashboard access, Other
• What would make you trust an external construction partner enough to give them authority over schedule levers?

Commissioning, Contingency, and the Final Gate

• What commissioning standards and acceptance tests must be complete to declare the space ready (e.g., clinical equipment integration, HVAC balancing, IT systems)?
• How do you prefer contingency to be managed—pooled owner contingency, contractor contingency in GMP, or a hybrid approach? Options: Owner contingency only, Contractor contingency within GMP, Hybrid with agreed triggers, Undecided / need recommendation
• What contingency triggers should automatically prompt executive escalation (e.g., >X days delay, >Y% cost exposure, critical equipment delivery miss)?
• Who leads commissioning and acceptance on your side (Facilities, Clinical Engineering, IT), and who will be our daily point of contact for readiness signoffs? Options: Facilities, Clinical Engineering, IT/Infrastructure, Vendor/Equipment rep, Other
• Are there occupancy phasing priorities (which areas must be ready first) and non‑negotiable handover sequences we should plan around?

What Would Make You Say Yes to Moving Forward?

• What commercial alignments would you require to feel comfortable (shared savings, GMP with open books, fixed fee, milestone payments)? Options: GMP with transparent open books, Fixed price contract, Cost‑plus with fee, Shared savings model, Milestone‑based payments
• What bonding, insurance, or contract assurances are mandatory for your procurement team before awarding a construction contract? Options: Performance bond, Payment bond, Professional liability, Builders risk insurance, Specific limits required, Other
• What governance cadence would you prefer during construction (weekly operational, monthly executive, quarterly board updates)? Options: Weekly operational, Biweekly program, Monthly executive, Quarterly board
• What would be a reasonable small‑step pilot (deliverable in 30–90 days) that would demonstrate our ability to lock budget and schedule before full commitment? Options: Early cost model & risk register, Mobilization readiness review, Critical‑path validation with trade commitments, Preconstruction study with phased schedule, Other
• Is there anything we haven’t asked that, if we understood it now, would change how we approach your project?